IL152177A0 - Piperazine and piperidine compounds - Google Patents
Piperazine and piperidine compoundsInfo
- Publication number
- IL152177A0 IL152177A0 IL15217701A IL15217701A IL152177A0 IL 152177 A0 IL152177 A0 IL 152177A0 IL 15217701 A IL15217701 A IL 15217701A IL 15217701 A IL15217701 A IL 15217701A IL 152177 A0 IL152177 A0 IL 152177A0
- Authority
- IL
- Israel
- Prior art keywords
- piperazine
- piperidine compounds
- piperidine
- compounds
- Prior art date
Links
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 title 2
- 150000003053 piperidines Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00201699 | 2000-05-12 | ||
PCT/EP2001/005320 WO2001085725A1 (en) | 2000-05-12 | 2001-05-10 | Piperazine and piperidine compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
IL152177A0 true IL152177A0 (en) | 2003-05-29 |
Family
ID=8171488
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15217701A IL152177A0 (en) | 2000-05-12 | 2001-05-10 | Piperazine and piperidine compounds |
IL152177A IL152177A (en) | 2000-05-12 | 2002-10-08 | Piperazine and piperidine compounds, |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL152177A IL152177A (en) | 2000-05-12 | 2002-10-08 | Piperazine and piperidine compounds, |
Country Status (28)
Country | Link |
---|---|
US (2) | US6911448B2 (da) |
EP (1) | EP1283838B1 (da) |
JP (1) | JP2003532729A (da) |
CN (1) | CN1174979C (da) |
AR (1) | AR028443A1 (da) |
AT (1) | ATE255578T1 (da) |
AU (2) | AU6392701A (da) |
BR (1) | BR0110592A (da) |
CA (1) | CA2405971C (da) |
CZ (1) | CZ301464B6 (da) |
DE (1) | DE60101386T2 (da) |
DK (1) | DK1283838T3 (da) |
DZ (1) | DZ3370A1 (da) |
ES (1) | ES2211809T3 (da) |
HK (1) | HK1055952A1 (da) |
HU (1) | HUP0302016A2 (da) |
IL (2) | IL152177A0 (da) |
MX (1) | MXPA02011084A (da) |
NO (1) | NO323778B1 (da) |
NZ (1) | NZ522116A (da) |
PL (1) | PL198857B1 (da) |
PT (1) | PT1283838E (da) |
RU (1) | RU2261250C2 (da) |
SK (1) | SK286778B6 (da) |
TR (1) | TR200302294T4 (da) |
UA (1) | UA72337C2 (da) |
WO (1) | WO2001085725A1 (da) |
ZA (1) | ZA200208537B (da) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2405971C (en) * | 2000-05-12 | 2010-03-30 | Solvay Pharmaceuticals B.V. | New piperazine and piperidine compounds |
AU2002322539B2 (en) | 2001-07-20 | 2007-09-27 | Psychogenics Inc. | Treatment for attention-deficit hyperactivity disorder |
WO2004000837A1 (ja) * | 2002-06-25 | 2003-12-31 | Sumitomo Pharmaceuticals Co., Ltd. | 新規なベンズオキサゾリノン誘導体 |
ES2232292B1 (es) * | 2003-07-30 | 2006-11-01 | Laboratorios Del Dr. Esteve, S.A. | Compuestos sulfonamidicos derivados de benzoxazinona, su preparacion y uso como medicamentos. |
EP1595542A1 (en) * | 2004-03-26 | 2005-11-16 | Solvay Pharmaceuticals B.V. | Transdermal iontophoretic delivery of piperazinyl-2(3H)-benzoxazolone compounds |
US7596407B2 (en) | 2004-03-26 | 2009-09-29 | Solvay Pharmaceuticals, B.V. | Transdermal iontophoretic delivery of piperazinyl-2(3H)-benzoxazolone compounds |
AR058022A1 (es) * | 2005-08-22 | 2008-01-23 | Solvay Pharm Bv | Derivados de benzooxazoles, composiciones farmaceuticas y su uso para el tratamiento de desordenes del sistema nervioso. |
ATE417834T1 (de) * | 2005-08-22 | 2009-01-15 | Solvay Pharm Bv | N-oxide als prodrugs von piperazin- und piperidinderivaten |
US7750013B2 (en) | 2005-08-22 | 2010-07-06 | Solvay Pharmaceuticals, B.V. | N-oxides as prodrugs of piperazine and piperidine derivatives |
US20070275977A1 (en) * | 2006-05-02 | 2007-11-29 | Van Aar Marcel P | N-oxides of pyridylmethyl -piperazine and -piperidine derivatives |
US8106056B2 (en) | 2006-06-16 | 2012-01-31 | Solvay Pharmaceuticals B.V. | Combination preparations comprising bifeprunox and a dopamine agonist |
JP2010511661A (ja) | 2006-12-07 | 2010-04-15 | エフ.ホフマン−ラ ロシュ アーゲー | V1a受容体アンタゴニストとしてのスピロ−ピペリジン誘導体 |
DE602007006989D1 (en) | 2006-12-07 | 2010-07-15 | Hoffmann La Roche | Spiropiperidinderivate |
EP2102186B1 (en) | 2006-12-08 | 2011-10-05 | F. Hoffmann-La Roche AG | Indoles |
US8071622B2 (en) | 2006-12-08 | 2011-12-06 | Hoffman-La Roche Inc. | Indoles |
AU2007338115A1 (en) | 2006-12-22 | 2008-07-03 | F. Hoffmann-La Roche Ag | Spiro-piperidine derivatives |
CN101918382A (zh) * | 2008-01-15 | 2010-12-15 | 雅培卫生保健产品有限责任公司 | 联苯芦诺衍生物 |
KR102374044B1 (ko) | 2016-08-26 | 2022-03-14 | 익스시바 게엠베하 | 조성물 및 그의 방법 |
WO2020022431A1 (ja) * | 2018-07-27 | 2020-01-30 | 中国塗料株式会社 | 防汚塗料組成物、防汚塗膜、防汚塗膜付き基材及びその製造方法、並びに補修方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60126275A (ja) * | 1983-12-13 | 1985-07-05 | Otsuka Pharmaceut Co Ltd | ベンゾチアゾ−ル誘導体 |
FR2567884B1 (fr) * | 1984-07-19 | 1987-03-06 | Roussel Uclaf | Nouveaux derives de l'indole, leur preparation, leur application comme medicaments et les compositions les renfermant |
DE3571436D1 (en) | 1984-12-21 | 1989-08-17 | Duphar Int Res | New pharmaceutical compositions having anti-psychotic properties |
EP0189612B1 (en) * | 1984-12-21 | 1992-11-04 | Duphar International Research B.V | New pharmaceutical compositions having a psychotropic activity |
US6225312B1 (en) * | 1996-03-29 | 2001-05-01 | Duphar International Research B.V. | Piperazine and piperidine compounds |
GB9811879D0 (en) * | 1998-06-03 | 1998-07-29 | Knoll Ag | Therapeutic agents |
UA71590C2 (en) * | 1998-11-13 | 2004-12-15 | Duphar Int Res | Piperazine and piperidine derivatives |
US20030186838A1 (en) * | 2000-05-12 | 2003-10-02 | Feenstra Roelof W. | Use of compounds having combined dopamine d2, 5-ht1a and alpha adrenoreceptor agonistic action for treating cns disorders |
CA2405971C (en) * | 2000-05-12 | 2010-03-30 | Solvay Pharmaceuticals B.V. | New piperazine and piperidine compounds |
-
2001
- 2001-05-10 CA CA2405971A patent/CA2405971C/en not_active Expired - Fee Related
- 2001-05-10 RU RU2002133458/04A patent/RU2261250C2/ru not_active IP Right Cessation
- 2001-05-10 JP JP2001582326A patent/JP2003532729A/ja not_active Ceased
- 2001-05-10 HU HU0302016A patent/HUP0302016A2/hu unknown
- 2001-05-10 MX MXPA02011084A patent/MXPA02011084A/es active IP Right Grant
- 2001-05-10 EP EP01938214A patent/EP1283838B1/en not_active Expired - Lifetime
- 2001-05-10 BR BR0110592-2A patent/BR0110592A/pt not_active IP Right Cessation
- 2001-05-10 WO PCT/EP2001/005320 patent/WO2001085725A1/en active IP Right Grant
- 2001-05-10 PL PL358201A patent/PL198857B1/pl not_active IP Right Cessation
- 2001-05-10 DK DK01938214T patent/DK1283838T3/da active
- 2001-05-10 SK SK1587-2002A patent/SK286778B6/sk not_active IP Right Cessation
- 2001-05-10 AU AU6392701A patent/AU6392701A/xx active Pending
- 2001-05-10 CN CNB018093302A patent/CN1174979C/zh not_active Expired - Fee Related
- 2001-05-10 DZ DZ013370A patent/DZ3370A1/xx active
- 2001-05-10 ES ES01938214T patent/ES2211809T3/es not_active Expired - Lifetime
- 2001-05-10 IL IL15217701A patent/IL152177A0/xx unknown
- 2001-05-10 TR TR2003/02294T patent/TR200302294T4/xx unknown
- 2001-05-10 CZ CZ20023721A patent/CZ301464B6/cs not_active IP Right Cessation
- 2001-05-10 DE DE60101386T patent/DE60101386T2/de not_active Expired - Lifetime
- 2001-05-10 AU AU2001263927A patent/AU2001263927B2/en not_active Ceased
- 2001-05-10 PT PT01938214T patent/PT1283838E/pt unknown
- 2001-05-10 AT AT01938214T patent/ATE255578T1/de active
- 2001-05-10 US US10/257,677 patent/US6911448B2/en not_active Expired - Fee Related
- 2001-05-10 NZ NZ522116A patent/NZ522116A/en not_active IP Right Cessation
- 2001-05-11 AR ARP010102239A patent/AR028443A1/es active IP Right Grant
- 2001-10-05 UA UA2002129990A patent/UA72337C2/uk unknown
-
2002
- 2002-10-08 IL IL152177A patent/IL152177A/en not_active IP Right Cessation
- 2002-10-22 ZA ZA200208537A patent/ZA200208537B/en unknown
- 2002-11-08 NO NO20025365A patent/NO323778B1/no not_active IP Right Cessation
-
2003
- 2003-11-12 HK HK03108190A patent/HK1055952A1/xx not_active IP Right Cessation
-
2005
- 2005-05-16 US US11/129,465 patent/US7297699B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0030710D0 (en) | Piperazine derivatives | |
AU8395501A (en) | Piperazine derivatives | |
DZ3306A1 (fr) | Derives de piperazine | |
AU6943701A (en) | Tetrahydropyridino or piperidino heterocyclic derivatives | |
IL148964A0 (en) | Piperazine compounds | |
NO20023787D0 (no) | Piperazin- og piperidinderivater | |
PL347635A1 (en) | New piperazine and piperidine compounds | |
IL152177A0 (en) | Piperazine and piperidine compounds | |
EP1313477A4 (en) | COMPILATIONS AND METHODS | |
PL355654A1 (en) | Piperidine and piperazine derivatives which function as 5-ht2a | |
EP1274424A4 (en) | CONNECTIONS AND PROCEDURE | |
GB0106177D0 (en) | Piperazine derivatives | |
IL126295A0 (en) | New piperazine and piperidine compounds | |
IL151178A0 (en) | Substituted piperazine compounds | |
GB0128984D0 (en) | Packer | |
PL353590A1 (en) | Piperidine alcohols | |
EP1343796A4 (en) | COMPOUNDS AND METHODS | |
GB0009479D0 (en) | Antihistaminic compounds | |
PT1131308E (pt) | Novos compostos de piperazina e piperidina | |
AU2002224105A1 (en) | Piperidine compounds and medicinal use thereof | |
CA89153S (en) | Headboard | |
GB9904614D0 (en) | Piperidines | |
AU142209S (en) | Jamb | |
AU7035601A (en) | Novel compounds and methods | |
GB0104583D0 (en) | Piperidine derivatives |